{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:14:59Z","timestamp":1783160099913,"version":"3.54.6"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025MS1221"],"award-info":[{"award-number":["ZR2025MS1221"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273969"],"award-info":[{"award-number":["82273969"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD1800504"],"award-info":[{"award-number":["2025ZD1800504"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110005","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:47:19Z","timestamp":1779173239000},"page":"110005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of a pyrazolo[3,4-b]pyridine chemotype for dual focal adhesion kinase 1\/2 (FAK1\/2) targeting in triple-negative breast cancer"],"prefix":"10.1016","volume":"179","author":[{"given":"Huirong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huicong","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qikun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110005_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"25","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.110005_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","article-title":"An overview of triple-negative breast cancer","volume":"293","author":"Kumar","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.bioorg.2026.110005_bb0015","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1007\/s12672-025-03745-z","article-title":"From cold to hot tumors: feasibility of applying therapeutic insights to TNBC","volume":"16","author":"Yan","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bioorg.2026.110005_bb0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/0113892010303244240718075729","article-title":"Recent advances in immunotherapy and targeted therapy of triple negative breast Cancer","volume":"26","author":"Shewale","year":"2025","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bioorg.2026.110005_bb0025","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrc3792","article-title":"FAK in cancer: mechanistic findings and clinical applications","volume":"14","author":"Sulzmaier","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110005_bb0030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1006\/geno.1996.0149","article-title":"Molecular cloning and assignment of FAK2, a novel human focal adhesion kinase, to 8p11.2-p22 by nonisotopic in situ hybridization","volume":"32","author":"Herzog","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.bioorg.2026.110005_bb0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/376737a0","article-title":"Protein tyrosine kinase PYK2 involved in ca(2+)-induced regulation of ion channel and MAP kinase functions","volume":"376","author":"Lev","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110005_bb0040","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/s41467-026-69899-8","article-title":"Eukaryote initiation factor 6 modulates small-cell lung carcinoma plasticity via the integrin-FAK signaling axis","volume":"17","author":"Peng","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110005_bb0045","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.immuni.2023.06.001","article-title":"Lipids regulate peripheral serotonin release via gut CD1d","volume":"56","author":"Luo","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.bioorg.2026.110005_bb0050","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/onc.2015.334","article-title":"Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma","volume":"35","author":"Meads","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.110005_bb0055","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41419-018-1005-z","article-title":"PYK2 negatively regulates the hippo pathway in TNBC by stabilizing TAZ protein","volume":"9","author":"Kedan","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.110005_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ccell.2018.11.016","article-title":"Tinagl1 suppresses triple-negative breast cancer progression and metastasis by simultaneously inhibiting integrin\/FAK and EGFR signaling","volume":"35","author":"Shen","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2026.110005_bb0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13046-019-1056-8","article-title":"Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells","volume":"38","author":"Rigiracciolo","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110005_bb0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1158\/0008-5472.CAN-16-1797","article-title":"Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4-NDRG1 Axis","volume":"77","author":"Verma","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110005_bb0075","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.3390\/cimb45090446","article-title":"Targeting FAK\/PYK2 with SJP1602 for anti-tumor activity in triple-negative breast Cancer","volume":"45","author":"Jeon","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.110005_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115192","article-title":"Design, synthesis and evaluation of nitric oxide releasing derivatives of 2,4-diaminopyrimidine as novel FAK inhibitors for intervention of metastatic triple-negative breast cancer","volume":"250","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110005_bb0085","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1074\/jbc.M809038200","article-title":"Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design","volume":"284","author":"Han","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110005_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118370","article-title":"Structural optimization and biological evaluation of 5-fluoro-7H-pyrrolo[2,3- d]pyrimidine derivatives as potent FAK inhibitors for the treatment of triple negative breast cancers (TNBC)","volume":"302","author":"Zhang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110005_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106792","article-title":"Design, synthesis and biological evaluation of 4-arylamino-pyrimidine derivatives as focal adhesion kinase inhibitors","volume":"140","author":"Long","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110005_bb0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4155\/fmc-2022-0279","article-title":"Design, synthesis and antitumor activity of novel pyran-functionalized uracil derivatives: docking studies","volume":"15","author":"Shehta","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110005_bb0105","first-page":"257","article-title":"Polyfunctionalized Thieno[2,3-b]pyridine compounds: preparation, DFT calculations, molecular docking studies, and agricultural potency evaluation against Aphis gossypii","volume":"6","author":"Husssein","year":"2026","journal-title":"ACS Agric. Sci. Technol."},{"key":"10.1016\/j.bioorg.2026.110005_bb0110","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1016\/j.bmcl.2016.10.092","article-title":"Selectivity switch between FAK and Pyk2: macrocyclization of FAK inhibitors improves Pyk2 potency","volume":"26","author":"Farand","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110005_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113116","article-title":"Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment","volume":"151","author":"Wu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110005_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13046-022-02396-0","article-title":"Focal adhesion kinase (FAK)-hippo\/YAP transduction signaling mediates the stimulatory effects exerted by S100A8\/A9-RAGE system in triple-negative breast cancer (TNBC)","volume":"41","author":"Rigiracciolo","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110005_bb0125","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1038\/s41388-021-01731-7","article-title":"CTGF regulates cell proliferation, migration, and glucose metabolism through activation of FAK signaling in triple-negative breast cancer","volume":"40","author":"Kim","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.110005_bb0130","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1038\/s41388-021-01798-2","article-title":"The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion","volume":"40","author":"Xu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.110005_bb0135","article-title":"LncRNA FAISL inhibits calpain 2-mediated proteolysis of FAK to promote progression and metastasis of triple negative breast Cancer","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioorg.2026.110005_bb0140","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccell.2025.02.001","article-title":"FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma","volume":"43","author":"Lubrano","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2026.110005_bb0145","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2539442","article-title":"Inhibition of FAK promotes pancreatic cancer immunotherapy by mediating CXCL10 secretion to enhance CD8+ T cell infiltration","volume":"14","author":"Shi","year":"2025","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bioorg.2026.110005_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262010108","article-title":"Kinome-wide screening identifies FAK as a novel post-translational regulator of PD-L1 stability and immune evasion in triple-negative breast Cancer","volume":"26","author":"Boyd","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110005_bb0155","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1016\/j.jmb.2014.08.014","article-title":"Structural and mechanistic insights into the interaction between Pyk2 and paxillin LD motifs","volume":"426","author":"Vanarotti","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.110005_bb0160","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1021\/acs.jmedchem.1c00459","article-title":"Identification of Thieno[3,2-d]pyrimidine derivatives as dual inhibitors of focal adhesion kinase and FMS-like tyrosine kinase 3","volume":"64","author":"Cho","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110005_bb0165","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41596-022-00771-x","article-title":"Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications","volume":"18","author":"Malinovska","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2026.110005_bb0170","doi-asserted-by":"crossref","first-page":"11419","DOI":"10.1021\/acs.jmedchem.5c00375","article-title":"Design, synthesis, and evaluation of Pyrazolopyridine derivatives as novel calreticulin (CALR) ligands that inhibit triple-negative breast Cancer (TNBC) via inducing calcium overloading","volume":"68","author":"Lu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110005_bb0175","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4161\/cbt.9.10.11434","article-title":"PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments","volume":"9","author":"Tanjoni","year":"2010","journal-title":"Cancer Biol. Ther."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:15:31Z","timestamp":1783156531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826005419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S0045206826005419"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110005","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a pyrazolo[3,4-b]pyridine chemotype for dual focal adhesion kinase 1\/2 (FAK1\/2) targeting in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110005"}}